This includes personalized dietary recommendations, increased physical activity, and behavioral strategies tailored to your lifestyle
The survey underneath it was fielded in December 2025 by ACUPOLL Precision Research and released publicly on February 24, 2026
Our study comparing GLP-1RAs with other anti-diabetes medications in T2DM patients with and without obesity, showed no increased risk of bowel obstruction
This growth reflects the increasing demand for therapies that target complex disease mechanisms, such as cancer, autoimmune disorders, and cardiovascular diseases (CVDs)
By lowering your blood sugar in all these ways, Trulicity also helps lower your risk of heart problems
Se administra por va subcutnea una vez a la semana a cualquier hora del da, con o sin alimentos